Torsemide
34 NDCs across 10 manufacturers|34 Generic,0 Brand
Torsemide is used to treat acute kidney injury, ascites, edema, heart failure, hypertension and chronic kidney failure, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 23, 1993, and the first generic was approved May 14, 2002. FDA's Orange Book lists 20 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $60 million on Torsemide across 3.0 million claims for 739,000 beneficiaries.
Torsemide is available as 34 NDCs from 10 manufacturers (34 generic, 0 brand), with NADAC prices from $0.06 to $0.28 per EA — the most expensive product costs about 4.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
34
34G / 0B
Manufacturers
10
competing in market
Price Spread
$0.06 – $0.28
per EA
7d Activity
avg -5.6% WoW · of 34 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Loop Diuretic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing TORSEMIDE(1 pricing outlier)
Frequently Asked Questions
What is Torsemide used to treat?
Torsemide is used to treat acute kidney injury, ascites, edema, heart failure, hypertension and chronic kidney failure, per the National Library of Medicine's MED-RT classification.
When did Torsemide become available as a generic?
FDA approved the first generic Torsemide (ANDA) on May 14, 2002. The Orange Book currently lists 20 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Torsemide?
In 2024, Medicare Part D spent $60 million on Torsemide across 3.0 million claims for 739,000 beneficiaries.
How many Torsemide products are on the market?
The Torsemide drug market contains 34 NDCs from 10 manufacturers — 34 generic and 0 brand products.
What is the price range for Torsemide?
NADAC reference prices for Torsemide range from $0.0573 to $0.2758 per EA — the most expensive product costs about 4.8× the cheapest.
Which manufacturers make Torsemide?
10 manufacturers list Torsemide in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (5), Rising Pharma Holdings Inc. (4), Heritage Pharmaceuticals Inc. (4), AvPAK (4), Aurobindo Pharma Limited (4).
How has the price of Torsemide changed recently?
Over the past 7 days, 0 Torsemide NDCs rose and 30 fell, with a market-wide average change of -5.6%.